✦ LIBER ✦

Integrins as signaling molecules and targets for tumor therapy

✍ Scribed by Ruoslahti, Erkki

Book ID: 109884779
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 463 KB
Volume: 51
Category: Article
ISSN: 0085-2538
DOI: 10.1038/ki.1997.193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integrin-targeted paclitaxel nanoliposom

Integrin-targeted paclitaxel nanoliposomes for tumor therapy

✍ Shuyan Meng; Bo Su; Wei Li; Yongmei Ding; Liang Tang; Wei Zhou; Yin Song; Zhou C 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 541 KB

Fibronectin as target for tumor therapy

✍ Manuela Kaspar; Luciano Zardi; Dario Neri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 347 KB 👁 1 views

During cancer progression, the extracellular matrix (ECM) of the tissue in which the tumor grows is extensively remodeled, both by degradation of preexisting ECM molecules and by the neosynthesis of ECM components, which in many cases are not present in the ECM of normal tissues. Fibronectin (FN), a

Integrins as therapeutic targets for ang

Integrins as therapeutic targets for angiogenesis and metastasis

✍ Mohit Trikha 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 32 KB

Signaling pathways in apoptosis as poten

Signaling pathways in apoptosis as potential targets for cancer therapy

✍ Pearl Huang; Allen Oliff 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Signaling Pathways as Specific Pharmacol

Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch

✍ Carter, Yvette; Jaskula-Sztul, Renata; Chen, Herbert; Mazeh, Haggi 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 282 KB

Tumor progression—targets for differenti

Tumor progression—targets for differential therapy

✍ Arthur B. Pardee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract Differential killing of the patient's cancer cells versus normal cells is a necessity for chemotherapy. Advantage can be taken of close regulations of gene expression and of enzyme activity that are essential for normal cell functioning, and that are altered during tumor progression. Su